13D Filing: Galen Partners V, L.L.C. and Quotient Ltd (QTNT)

Page 6 of 16

Page 6 of 16 – SEC Filing


CUSIP No. G73268 107 13D
  1. 

Name of
Reporting Persons

Zubeen Shroff

  2.

Check the Appropriate Box if a Member
of a Group (see instructions)

(a)  ☐        (b)  ☒(1)

  3.

SEC USE ONLY

  4.

Source of Funds (see instructions)

AF

  5.

Check if Disclosure of Legal
Proceedings Is Required Pursuant to Items 2(d) or 2(e)  ☐

  6.

Citizenship or Place of
Organization

United States

Number of

Shares

Beneficially

Owned by

Each

Reporting

Person

With

  7. 

Sole Voting Power

20,555 (6)

  8.

Shared Voting Power

7,178,370(5)

  9.

Sole Dispositive Power

20,555 (6)

10.

Shared Dispositive Power

7,178,370(5)

11.

Aggregate Amount Beneficially Owned by Each Reporting Person

7,349,629(5)(6)

12.

Check if the Aggregate Amount in Row
(11) Excludes Certain Shares (see instructions)  ☐

13.

Percent of Class Represented by Amount
in Row 11

16.0%(3)

14.

Type of Reporting Person (see
instructions)

IN

(1) This schedule is filed by Galen Partners V LP (Galen LP), Galen Partners International V LP (Galen International), Galen Management LLC (Management), Galen Partners V, L.L.C.
(Galen), Zubeen Shroff, L. John Wilkerson and David Jahns (collectively, the Listed Persons). Galen is the General Partner of Galen LP and Galen International and the Listed Persons are the managing directors of Galen. Galen
LP, Galen International, Management, Galen and the Listed Persons expressly disclaim status as a group for purposes of this Schedule 13D.
(3) The percentage is based upon 45,542,808 Ordinary Shares outstanding, which is the sum of (i) 37,688,125 Ordinary Shares outstanding as of August 4, 2017, as reported in the Issuers Quarterly Report on Form 10-Q
for the quarterly period ended June 30, 2017 filed with the Securities and Exchange Commission on August 8, 2017 and (ii) 7,874,683 shares of Ordinary Shares issued by the Issuer pursuant to the private placement described in the Issuers
Current Report on Form 8-K filed with the Securities and Exchange Commission on October 25, 2017.
(5) Includes 386,695 and 33,033 ordinary shares that Galen LP and Galen International, respectively have the right to acquire within 60 days of October 25, 2017 pursuant to outstanding warrants to purchase the Issuers
Ordinary Shares.
(6) Includes 17,937 shares issuable upon stock options and 2,618 shares issuable upon the vesting of restricted stock units, that the reporting person has the right to acquire within 60 days of October 25, 2017.

Follow Quotient Ltd (NASDAQ:QTNTQ)

Page 6 of 16